Clinical implications of germline mutations in breast cancer: TP53

ConclusionsIdentifying aTP53 mutation in a gene panel test is a challenging result for the patient and clinician due to the high risk of second primaries and the lack of consensus about surveillance.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research